There’s still little evidence of the big things that have long been expected for the JSE’s bombed-out small-cap counters so far in 2019. With the overall market — courtesy of an early resource sector rally and sprightlier performance from market heavyweights like Naspers, British American Tobacco, Richemont and AB InBev — looking firmer in the first quarter, there was a more than reasonable expectation from wide-eyed punters that small-cap counters might catch this swelling wave of improved sentiment. Not quite. Risk aversion still seems prevalent in 2019, which probably means further outflows from smaller-cap counters — perceived as higher risk — to the relative safety of recovering blue-chip counters. Some of the most popular small-cap counters have actually got cheaper — and, in some instances, a whole lot cheaper. There are more than a few notable mid-cap fizzles — including PSG-owned agribusiness Zeder, health-care group Ascendis (now a small cap by definition), Blue Label Tele...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.